Investors

In this section of the Rock Creek Pharmaceuticals Investor pages, you'll find our news releases. The releases are listed in chronological order and are archived by year.

Archives: Search / 2016 / 2015 / 2014

2015 Archives

Dec 10, 2015

Rock Creek Pharmaceuticals, Inc., (OTCQB: RCPI), a clinical stage, drug development company which is focused on the application of its lead compound to treat chronic inflammatory conditions,...

More
Dec 3, 2015

Rock Creek Pharmaceuticals, Inc., (OTCQB: RCPI), a clinical stage drug development company focused on the application of its lead compound being developed to treat chronic inflammatory conditions,...

More
Nov 19, 2015

Rock Creek Pharmaceuticals, Inc., (OTCQB: RCPI), a clinical stage drug development company focused on the application of its lead compound being developed to treat chronic inflammatory conditions,...

More
Nov 9, 2015
Allowance for the Administration of Anatabine to Treat Autism Spectrum and Seizure Disorders and Third Quarter Results

Rock Creek Pharmaceuticals, Inc., (OTCPK: RCPI), a clinical stage drug development company focused on the application of its lead compound being developed to treat chronic inflammatory conditions,...

More
Oct 21, 2015

Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI), a clinical stage, drug development company which is focused on the application of its lead compound to treat chronic inflammatory conditions,...

More
Oct 15, 2015

Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI), a clinical stage drug development company focused on the application of its lead compound being developed to treat chronic inflammatory...

More
Oct 15, 2015

Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI), a clinical stage, drug development company which is focused on the application of its lead compound being developed to treat chronic inflammatory...

More
Aug 19, 2015

Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI), a clinical stage, drug development company which has focused on the application of its lead compounds to chronic inflammatory conditions,...

More
Aug 14, 2015

Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI), a clinical stage, drug development company which has focused on the application of its lead compound to chronic inflammatory conditions, announced...

More
Aug 10, 2015

Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI), a clinical stage, drug development company which has focused on the application of its lead compound to chronic inflammatory conditions, announced...

More
Jul 1, 2015

Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI), a drug development company focused on chronic inflammatory disease and neurologic disorders, announced today the results of a human proof of...

More
Jun 19, 2015

Rock Creek Pharmaceuticals, Inc. (NASDAQ: RCPI) (Rock Creek), a drug development company focused on chronic inflammatory disorders, announced that today it has closed its previously announced $3.7...

More
Jun 17, 2015

Rock Creek Pharmaceuticals, Inc. (NASDAQ: RCPI) (Rock Creek), a drug development company focused on chronic inflammatory disorders, announced today that it has entered into definitive agreements...

More
Jun 11, 2015

Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI), a drug development company focused on chronic inflammatory disease and neurologic disorders, announced today an update on its clinical and...

More
May 12, 2015

Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI), a drug development company focused on chronic inflammatory disease and neurologic disorders, announced today its financial results for the first...

More
Apr 21, 2015

Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI), a drug development company focused on the treatment of chronic inflammatory disorders, announced that the Company has made a key independent...

More
Mar 12, 2015

Clinical Update: Gained approval of a Clinical Trial Application (CTA) in Europe during January 2015 allowing study of Company's lead compound, Anatabine Citrate Completes recruitment and initial...

More
Jan 30, 2015
- Phase I Trial begins in the United Kingdom -

Rock Creek Pharmaceuticals, Inc. (NASDAQ: RCPI), a drug development company focused on chronic inflammatory disorders, announced today that the United Kingdom's Medicines Healthcare Products...

More
Jan 5, 2015

Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI), a drug development company focused on chronic inflammatory disease and neurologic disorders, announced that the Company's presentation at the...

More
 

print email rss